| Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD |
| Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015 |
| Abstract : |
| PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| PubMedID: 25973909 |
| Title : The scopolamine model as a pharmacodynamic marker in early drug development - Lenz_2012_Psychopharmacology.(Berl)_220_97 |
| Author(s) : Lenz RA , Baker JD , Locke C , Rueter LE , Mohler EG , Wesnes K , Abi-Saab WM , Saltarelli MD |
| Ref : Psychopharmacology (Berl) , 220 :97 , 2012 |
| Abstract : |
| PubMedSearch : Lenz_2012_Psychopharmacology.(Berl)_220_97 |
| PubMedID: 21901320 |